¿Son útiles los factores pronóstico en la artritis reumatoide?

Reumatología Clínica - Tập 7 - Trang 339-342 - 2011
Montserrat Robustillo Villarino1, Jesús Rodríguez Moreno1
1Servicio de Reumatología, Hospital Universitario de Bellvitge, L’Hospitalet de Llobregat, Barcelona, España

Tài liệu tham khảo

Spector, 1990, Rheumatoid arthritis, Rheum Dis Clin North Am, 16, 513, 10.1016/S0889-857X(21)00886-3

Mau, 1991, Prediction of permanent work disability in a follow-up study of early rheumatoid arthritis: results of a tree structured analysis using recpam, Mau Semin Arthritis Rheum, 21, 4

Schneeberger, 2010, Factors associated with disability in patients with rheumatoid arthritis, J Clin Rheumatol, 16, 215, 10.1097/RHU.0b013e3181e92d25

Hetland, 2010, Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial, Ann Rheum Dis, 69, 1789, 10.1136/ard.2009.125534

Vvan Tuyl, 2010, European League against Rheumatism Committee to Define Remission for Clinical Trials. Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: a systematic review, Arthritis Care Res, 62, 108, 10.1002/acr.20021

Sanmarti, 2003, Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting, Rheumatology, 42, 1044, 10.1093/rheumatology/keg284

Gorman, 2004, Lack of association of the HLA-DRB1 shared epitope with rheumatoid nodules: an individual patient data meta-analysis of 3,272 caucasian patients with rheumatoid arthritis, Arthritis Rheum, 50, 753, 10.1002/art.20119

Katchamart, 2010, Predictors for remission in rheumatoid arthritis patients: A systematic review, Arthritis Care Res, 62, 1128, 10.1002/acr.20188

Van der Heijde, 2005, Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial, Ann Rheum Dis, 65, 328, 10.1136/ard.2005.035709

Burmester, 2008, Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study, Arthritis Rheum, 59, 32, 10.1002/art.23247

Pease, 1999, Does the age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors, Rheumatology, 38, 228, 10.1093/rheumatology/38.3.228

Molenaar, 2002, Influence of HLA polymorphism on persistent remission in rheumatoid arthritis, Ann Rheum Dis, 61, 351, 10.1136/ard.61.4.351

Hyrich, 2006, British Society for Rheumatology Biologics R. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register, Rheumatology, 45, 1558, 10.1093/rheumatology/kel149

Gossec, 2004, Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study, Ann Rheum Dis, 63, 675, 10.1136/ard.2003.010611

Forslind, 2007, Sex: a major predictor of remission in early rheumatoid arthritis?, Ann Rheum Dis, 66, 46, 10.1136/ard.2006.056937

Van der Heijde, 2007, Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis, Arthritis Rheum, 56, 3928, 10.1002/art.23141

Hyrich, 2006, Arthritis Rheum, 54, 1786, 10.1002/art.21830

Mottonen, 2002, Delay to institution of therapy and induction of remission using single-drug or combination-disease modifying antirheumatic drug therapy in early rheumatoid arthritis, Arthritis Rheum, 46, 894, 10.1002/art.10135

Radovits, 2010, Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis, Arth Care Res, 62, 362, 10.1002/acr.20105

Gonzalez, 2007, The widening mortality gap between rheumatoid arthritis patients and the general population, Arth Rheumat, 56, 3583, 10.1002/art.22979

Actualización de guía de práctica clínica para el manejo de la artritis reumatoide (GUIPCAR) en España 2007.